How to use the speech recognition tool?

NCT03490019

BBS

Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible
Visual Improvement.

Type: Interventional



Status of the trial: Inactive

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2018-04-01
  • Closing Date: 2020-08-01

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: national institution

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: